LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
Hantang Tiancheng (02726): Hong Kong public offering is oversubscribed 50.66 times, final offering price is HK$76.26 per share.
KEEP(03650) on March 27th repurchased 200,000 shares at a cost of HK$600,100.
Fantasia (01777) released its 2025 financial performance with a net loss attributable to shareholders of 9.186 billion yuan, an increase of 10.52% year-on-year.
Hantang Tiancheng (02726): Hong Kong public offering is oversubscribed 50.66 times, final offering price is HK$76.26 per share.
KEEP(03650) on March 27th repurchased 200,000 shares at a cost of HK$600,100.
Fantasia (01777) released its 2025 financial performance with a net loss attributable to shareholders of 9.186 billion yuan, an increase of 10.52% year-on-year.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
